Objectives. To explore barriers to care and characteristics associated with respondent-
reported perceived need for opioid use disorder (OUD) treatment and National Survey on …

Importance Buprenorphine is underutilized as a treatment for opioid use disorder (OUD);
state policies may improve buprenorphine access and utilization. Objective To assess …

Abstract Background Medicare disability beneficiaries (MDBs) have disproportionately high
risk of opioid use disorder (OUD) and related harms given high rates of comorbidities and …

Objective Medication for opioid use disorder (MOUD) is effective but underused. Measuring
the percentage of a provider's patients with an opioid use disorder (OUD) who receive …

To address the growing problem of unhealthy drug use, the US Preventive Services Task
Force (USPSTF) recently updated its recommendations on screening for unhealthy drug use …

Introduction Although opioid substitution coverage in France is high and patient care with
buprenorphine is mainly managed by general practitioners (GPs), buprenorphine sales …

Introduction Medications for opioid use disorder (MOUD) are the most effective treatment for
opioid use disorder (OUD) but remain underutilized. To reduce barriers to MOUD …

Objectives: Efforts to improve buprenorphine access for opioid use disorder have focused on
increasing the number of waivered providers. However, it is unknown how efforts to increase …

Background: The American Board of Medical Specialties recognized addiction medicine
(ADM) as a subspecialty in 2016, which was timely given the recent rise in substance use …

The opioid crisis is America's Ebola. Often fatal, complicated, with multiple ramifications that
go beyond just medicine to the core of our culture. Clinicians' response to pharma …